Janssen Biotech announced the submission of a Biologics License Application (BLA) to the FDA requesting approval of an investigational intravenous formulation of Simponi (golimumab) for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback